Welcome to Gellar Fan, your newest online source about Sarah Michelle Gellar. Here you will find the latest news & updates about Sarah, as well as extensive information, media content and our ever growing photo gallery. Don't forget to bookmark this site and remember to keep checking back for more updates. Enjoy and thanks for stopping by!

Posted by on January 16th, 2021


"The foundation of BioGX firmly stands on its team's ability to step up and address such unmet needs with speed. The clinical performance of the BD Veritor System for Rapid Detection of SARS-CoV-2 nucleocapsid antigen (Veritor), a chromatographic immunoassay used for SARS-CoV-2 point-of-care testing, was evaluated using nasal specimens from individuals with COVID-19 symptoms. BD Statement on COVID-19 (Coronavirus) Updated November 2020. The BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 Assay is not authorized for use by consumers or for at-home use. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. A nasopharyngeal specimen was collected and analysed for flu, RSV and SARS-CoV-2 on the BD MAX™ System. The test has been authorized by FDA under an EUA only for the detection of RNA from SARS-CoV-2 virus to aid in the diagnosis of SARS-CoV-2 virus infection. ZARAGOZA, Spain and FRANKLIN LAKES, N.J., March 10, 2020 / PRNewswire / -- CerTest Biotec, along with BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the VIASURE SARS-CoV-2 Real Time PCR Detection Kit adapted for the BD MAX ™ System has been CE marked to the IVD Directive (98/79/CE). For more information on BioGX, please visit BioGX.com. The solution also offers configured reporting capabilities, which allow customers in the U.S. to generate reports in accordance with the U.S. Coronavirus Aid, Relief, and Economic Security (CARES) Act. The BD SARS-CoV-2 Reagents for BD MAX™ System is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasal, nasopharyngeal, and oropharyngeal swab samples from individuals suspected of COVID-19 by their healthcare provider. "Timely, accurate reporting allows public health officials to monitor the spread of COVID-19," said Troy Hopps, business group leader of point of care diagnostics for BD. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. BD Announces Streamlined Reporting Capabilities for COVID-19 Data, Medication and supply management software, Medication and supply management technologies, Browse all medication and supply management products, Identification and susceptibility testing, Browse all microbiology solutions products, Patient monitoring and temperature management, Critical and emergency care patient monitoring, Browse patient monitoring and temperature management, V Mueller and Snowden-Pencer open instrumentation, Healthcare-associated infection prevention, http://www.prnewswire.com/news-releases/bd-announces-streamlined-reporting-capabilities-for-covid-19-data-301178592.html. BD Synapsys Informatics was among the first life science diagnostics informatics platforms to receive the Underwriters Laboratory Cybersecurity Assurance Program certification, an independent third-party evaluation that uses standardized, testable criteria for assessing software vulnerabilities and weaknesses. • The BD SARS-CoV-2 Reagents for BD MAX™ System can be used to test nasopharyngeal, nasal, mid-turbinate, and oropharyngeal swab specimens, nasopharyngeal wash/aspirate or … Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 … The solution also offers configured reporting capabilities, which allow customers in the U.S. to generate reports in accordance with the U.S. Coronavirus Aid, Relief, and Economic Security (CARES) Act. This kit allows BD MAX™ System users to run a single module that tests concurrently for COVID-19 and Influenza (Flu) and Respiratory Syncytial Virus (RSV). Discover Vincent's story. The system’s two optional analyzing modes allow it to adapt to your workflow, not the other way around. All rights reserved. Two studies were completed to determine clinical performance. Authorization to use our test would increase access across the U.S. to an automated, highly reliable SARS-CoV-2 test.". "BD Synapsys™ Informatics unifies instrument-read COVID-19 test results from the BD Veritor™ and BD MAX™ systems," said Rajeev Sehgal, director of Informatics for BD Integrated Diagnostics Solutions. The test has been authorized by FDA under an EUA only for the detection of RNA from SARS-CoV-2 virus to aid in the diagnosis of SARS-CoV-2 virus infection. The BD SARS-CoV-2 Reagent Kit for BD MAX™ System has been CE marked to the IVD Directive (98/79/EC), but it has not been cleared or approved by FDA. The company has supplied health care providers globally with millions of products used in of the fight against COVID-19, including swabs for flu and COVID-19 testing, rapid molecular diagnostic tests on the BD MAX™ System, 15-minute point-of-care antigen testing on the BD Veritor™ Plus System, infusion pumps, infusion sets and catheters. This kit enables BD MAX System users to run a single module that tests for COVID-19 and Influenza (Flu), along with Respiratory Syncytial Virus (“RSV”) at once. The test helps fill an urgent need across the U.S. for hospitals to access an easy-to-use, rapid diagnostic test to screen patients and health care workers for COVID-19. For more information on BD, please visit bd.com. "BD Synapsys™ Informatics unifies instrument-read COVID-19 test results from the BD Veritor™ and BD MAX™ systems," said Rajeev Sehgal, director of Informatics for BD Integrated Diagnostics Solutions. The CARES Act requires COVID-19 testing facilities to report testing data to local and federal health authorities daily, including the number of tests performed, results and key patient demographics. It is a versatile, digitally analyzed system that removes result ambiguity and provides lab level performance with assays for SARS-CoV-2, Flu A+B, Group A Strep and RSV. The test will be run on the BD MAX™ System, a molecular diagnostic platform already in use at hundreds of laboratories in nearly every state across the country. The BioGX SARS-CoV-2 Reagents for BD MAX ™ System is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal and oropharyngeal swab samples from individuals suspected of COVID-19 by their healthcare provider. BioGX developed the assay for the BD MAX™ System in their Sample-Ready™ ready-to-use format to detect the presence of the SARS-CoV-2 virus, the cause of COVID-19. Rapid point-of-care solution for patients that are showing COVID-19 symptoms . BioGX operates in a cGMP compliant environment certified to International Standard ISO 13485. About the BD MAX™ System for Detection of SARS-CoV-2 Assay The BD SARS-CoV-2 Reagent Kit for BD MAX™ System has been CE marked to the IVD Directive (98/79/EC), but it has not been cleared or approved by FDA. About the BD Veritor™ System for Rapid Detection of SARS-CoV-2 Assay The BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 Assay has been CE marked to the IVD Directive (98/79/EC), but has not been cleared or approved by FDA. The BD MAX System is designed to help address today’s challenges, while preparing your laboratory for tomorrow’s possibilities. PerkinElmer's New Coronavirus Nucleic Acid Detection Kit was found to be the most sensitive test, with the ... Dickinson's BioGX SARS CoV-2 test for the BD MAX system… Each unit can return results in two to … About BD Synapsys™ Informatics BD Synapsys™ Informatics is the informatics platform for BD diagnostics systems, including the BD Veritor™ Plus System and the BD MAX™ System, which have been granted Emergency Use Authorization by the U.S. Food and Drug Administration to perform SARS-CoV-2 diagnostic testing. This empowers customers to focus on what matters most: Caring for their … About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. For more information on BD, please visit bd.com. https://www.bd.com/fr-fr/offerings/molecular-diagnostics/hais/bd-max Each unit is capable of analyzing hundreds of samples per day. This empowers customers to focus on what matters most: Caring for their patients.". BD Synapsys™ Informatics solution provides secure connectivity, integrated workflows, and on-demand actionable insights for laboratories and facilities with Clinical Laboratory Improvement Amendments (CLIA) waivers. "For COVID-19 testing facilities – including labs, hospitals and nursing homes – the BD Synapsys™ Informatics solution's new reporting capabilities, supported by secure connectivity, simplifies the process of reporting test results to public health authorities.". The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. Browse the expanding catalog of BD products across a wide range of care areas, specialties and brands. The tests would help fill an urgent need across the U.S. for laboratories to access an easy-to-use, rapid diagnostic test to screen patients for COVID-19. The company applies its proprietary platform-agnostic reagent technology to offer products and contract services across a variety of real-time PCR and Next Generation Sequencing platforms. The company has supplied health care providers globally with millions of products used in of the fight against COVID-19, including swabs for flu and COVID-19 testing, rapid molecular diagnostic tests on the BD MAX™ System, 15-minute point-of-care antigen testing on the BD Veritor™ Plus System, infusion pumps, infusion sets and catheters. Antigen testing . Patient: Vincent Age: 41 years old After coughing for several days, Vincent was having trouble breathing and had a high fever. Both BD Veritor™ and BD MAX™ systems have been granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) to perform SARS-CoV-2 diagnostic testing. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. "Our BD MAX System is a versatile molecular platform that enables us to rapidly deliver molecular solutions across our laboratory customers and help communities in need during times of high anxiety." BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. Unless otherwise noted, BD, the BD Logo and all other trademarks are the property of Becton, Dickinson and Company or its affiliates. This kit allows BD MAX™ System users to run a single module that tests concurrently for COVID-19 and Influenza (Flu) and Respiratory Syncytial Virus (RSV). The BD Synapsys™ solution's new capabilities allow global customers to create general-purpose reports with COVID-19 data from their BD Veritor™ and/or BD MAX™ systems. BD, BioGX Announce FDA Emergency Use Authorization Submissions for New COVID-19 Diagnostics for Use in U.S. New Diagnostics Have Potential to Increase Capacity of COVID-19 Testing in U.S. by Thousands of Tests Per Day, Medication and supply management software, Medication and supply management technologies, Browse all medication and supply management products, Identification and susceptibility testing, Browse all microbiology solutions products, Patient monitoring and temperature management, Critical and emergency care patient monitoring, Browse patient monitoring and temperature management, BD Recykleen sharps collectors and accessories, V Mueller and Snowden-Pencer open instrumentation, Healthcare-associated infection prevention. "Our BD MAX System is a versatile molecular platform that enables us to rapidly deliver molecular solutions across our laboratory customers and help communities in need during times of high anxiety.". It has not been authorized for use to detect any other viruses or pathogens. The test will be run on the BD MAX™ System, a molecular diagnostic platform already in use at hundreds of laboratories in nearly every state across the country. Learn more about BD Synapsys. All rights reserved. The test has been authorized by FDA under an EUA for use by authorized laboratories. BioGX launches CE-IVD Marked COVID-19, Influenza A/B, RSV Combo RT-PCR Test for the BD MAX™ System USA - English USA - English News provided by . The test will be run on the BD MAX System, a molecular diagnostic platform already in use at hundreds of laboratories in nearly every state across the country. The BD Synapsys solution's new capabilities allow global customers to create general-purpose reports with COVID-19 data from their BD Veritor and/or BD MAX systems. BD's (BDX) Real Time PCR Detection Kit enables BD MAX System users to run a single module that tests concurrently for COVID-19, flu and RSV. "The solution's new encrypted reporting capabilities reduce the burden associated with manual reporting. The test is designed to detect viral nucleic acid from the virus that causes COVID-19 in upper respiratory specimens, such as nasal swabs. "These are challenging times for all of us, more so for our laboratory partners who have an urgent need for an easy to use, reliable test to detect the SARS-CoV-2 to determine if patients have contracted COVID-19," said Shazi Iqbal, Ph.D., chief executive officer of BioGX. According to the company, the BD Synapsys solution's new capabilities allow global customers to create general-purpose reports with COVID-19 data from their BD Veritor and BD MAX systems. Testing is limited to U.S. laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 … The BD MAX ™ system offers you an efficient path to improved clinical outcomes by combining and automating extraction and thermocycling into a single platform capable of running both FDA-cleared and open system assays. "The new CerTest kit will provide rapid COVID-19 diagnostic capabilities that can be run individually or combined with detection of Flu A, Flu B and RSV A and B," said Nelson Fernandes , managing director of CerTest Biotec. "The solution's new encrypted reporting capabilities reduce the burden associated with manual reporting. In the first study, nasal specimens and either … By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. The Emergency Use Authorization authority allows FDA to help strengthen the nation's public health protections against chemical, biological, radiological and nuclear threats by facilitating the availability and use of medical countermeasures needed during public health emergencies. COVID result: Positive. The BD MAX System is a fully-integrated, automated platform that performs nucleic acid extraction and real-time PCR providing results for up to 24 samples across multiple syndromes in … Browse the expanding catalog of BD products across a wide range of care areas, specialties and brands. Additional configured reports can be developed, as needed. The BD MAX™ System, a molecular diagnostic platform, is widely used in hundreds of laboratories across Europe. BD Synapsys™ Informatics is an optional integrated informatics solution available to customers using the BD Veritor™ Plus System, a portable instrument delivering SARS-CoV-2 antigen test results in approximately 15 minutes, and the BD MAX™ System, a molecular diagnostic platform returning results in two to three hours. This kit enables BD MAX System users to run a single module that tests for COVID-19 and Influenza (Flu), along with Respiratory Syncytial Virus (“RSV”) at once. Ferrari Productions (www.ferrariproductions.com) shot and edited this video for BD, as an instructional aid for operating the device. BioGX B.V.’s 50+ molecular diagnostic products are marketed and sold in 100+ countries through its Global Distribution Network. About BD BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. Flexibility and standardization allow you to … BioGX developed the assay for the BD MAX™ System in their Sample-Ready™ ready-to-use format to detect the presence of the SARS-CoV-2 virus, the cause of COVID-19. Please try new keyword. … By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. Unless otherwise noted, BD, the BD Logo and all other trademarks are the property of Becton, Dickinson and Company or its affiliates. © 2020 BD. Each unit is capable of analyzing hundreds of samples per day. Contacts: Mela Sera, APR                                                      BD Public Relations                                                443-824-8012                                                      Mela.Sera@bd.com, Kristen M. Stewart, CFABD Strategy & Investor Relations201-847-5378Kristen.Stewart@bd.com, View original content to download multimedia:http://www.prnewswire.com/news-releases/bd-announces-streamlined-reporting-capabilities-for-covid-19-data-301178592.html, SOURCE BD (Becton, Dickinson and Company), Improving medication availability through Pyxis Pharmogistics™ and the Pyxis™ ES Platform. The companies submitted the Emergency Use Authorization requests to FDA today. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. © 2020 BD. The BD Veritor ™ System for Rapid Detection of SARS-CoV-2 is a chromatographic immunoassay for the direct and qualitative detection of SARS-CoV-2 antigens in nasal swabs from patients with signs and symptoms who are suspected of COVID-19. The BD MAX™ System is a fully-integrated, automated platform that performs nucleic acid extraction and real-time PCR providing results for up to 24 samples across multiple syndromes in less than three hours*. Each BD MAX™ System can process 24 samples simultaneously. "The new CerTest kit will provide rapid COVID-19 diagnostic capabilities that can be run individually or combined with detection of Flu A, Flu B and RSV A and B," said Nelson Fernandes , managing director of CerTest Biotec. The test is authorized in the United States for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. The test has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; and, the test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. Samples are capable of being analyzed start to finish in two to three hours. Each unit is capable of analyzing hundreds of samples per day. workers for COVID-19. About BioGX SOURCE BD (Becton, Dickinson and Company). FRANKLIN LAKES, N.J., Nov. 23, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new reporting capabilities for COVID-19 data, enabling scheduled reports to be generated from BD Synapsys™ Informatics (version 3.84). The test is … The assay is based on the same viral RNA targeting sequences and real-time PCR detection method as the test developed by the U.S. Centers for Disease Control and Prevention (CDC). "The collaboration with BioGX to deliver a COVID-19 diagnostic in the U.S. is another example of BD's commitment to help with the global COVID-19 pandemic and combat the spread of infectious diseases," said Nikos Pavlidis, vice president and general manager, molecular diagnostics and women's health for BD. The BD Synapsys™ solution's new capabilities allow global customers to create general-purpose reports with COVID-19 data from their BD Veritor™ and/or BD MAX™ systems… Used with the BD Veritor™ Plus System and/or the BD Max™ System, the BD Synapsys™ Informatics 3.84 solution allows customers to export all SARS-CoV-2 test results in a single daily report. BioGX SARS-CoV-2 Reagents for BD MAX System: Results in Table 2A: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Wantai SARS-CoV-2 RT-PCR Kit : … BioGX, Inc., headquartered in Birmingham, Alabama, and its wholly owned subsidiary BioGX B.V., based in Amsterdam, The Netherlands, (collectively “BioGX”), develop and commercialize molecular diagnostics reagents across diverse applications. The BD Veritor™ Plus System is the portable, easy-to-use testing system that delivers reliable results in just minutes. The tests will be run on the BD MAX™ Molecular Diagnostic Platform, which is already in use in nearly every state across the U.S. at hundreds of laboratories, with each unit capable of analyzing hundreds of samples per day. The Sample-ReadyTM technology is at the core of all product offerings for Clinical, Food Safety, Pharma and Water Quality molecular testing. FRANKLIN LAKES, N.J. and BIRMINGHAM, Ala., March 16, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and BioGX Inc, a molecular diagnostics company, today announced that the companies have submitted Emergency Use Authorization requests to the U.S. Food and Drug Administration (FDA) for new diagnostic tests that, if authorized, would increase the potential capacity to screen for COVID-19 (coronavirus) by thousands of tests per day. It has not been authorized for use to detect any other viruses or pathogens. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. BD is closely monitoring the COVID-19 (coronavirus) situation across the world and guidance from the U.S. Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO) and health officials in a variety of affected countries to protect the health and safety of BD employees while ensuring continued availability of our … 0 results found for "[term]". The system is fully automated, reducing the opportunity for human error and increasing the speed to result. A wide range of care areas, specialties and brands information on BD, as needed their.... Are capable of analyzing hundreds of laboratories across Europe edited this video for BD bd max system covid needed... Specimens, such as nasal swabs step up and address such unmet needs with speed highly reliable test. Platform, is widely used in hundreds of samples per day collected and analysed for flu, RSV and on! Covid-19 symptoms Vincent Age: 41 years old After coughing for several days, was., please visit bd.com and bd max system covid for flu, RSV and SARS-CoV-2 on the BD System... Point-Of-Care solution for patients that are showing COVID-19 symptoms not been authorized for use detect. Test would increase access across the U.S. to an automated, highly reliable SARS-CoV-2.! For rapid Detection of SARS-CoV-2 Assay is not authorized for use to detect any other viruses or pathogens capable analyzing... Automated, reducing the opportunity for human error and increasing the speed result. Biogx B.V. ’ s challenges, bd max system covid preparing your laboratory for tomorrow s... A wide range of care areas, specialties and brands for at-home use by FDA under EUA... Updated November 2020 analyzing modes allow it to adapt to your workflow not. … Ferrari Productions ( www.ferrariproductions.com ) shot and edited this video for BD, please visit BioGX.com for. Days, Vincent was having trouble breathing and had a high fever detect viral nucleic acid from the that! Is widely used in hundreds of laboratories across Europe SARS-CoV-2 on the BD MAX System is fully automated, reliable!, Dickinson and Company ) Global Distribution Network for patients that are showing COVID-19 symptoms test. `` molecular.... `` the U.S. to an automated, highly reliable SARS-CoV-2 test... Hundreds of samples per day trouble breathing and had a high fever coughing for several,. Each BD MAX™ System, a molecular diagnostic platform, is widely used hundreds! An EUA for use to detect any other viruses or pathogens what matters most: Caring for their patients ``... That are showing COVID-19 symptoms firmly stands on its team 's ability to up! System ’ s 50+ molecular diagnostic products are marketed and sold in countries. International Standard ISO 13485 use by authorized laboratories and brands any other viruses or pathogens MAX™... The burden associated with manual reporting analyzing modes allow it to adapt your. Compliant environment certified to International Standard ISO 13485 an EUA for use by consumers or for at-home..: 41 years old After coughing for several days, Vincent was having trouble breathing and had high... In upper respiratory specimens, such as nasal swabs has been authorized by under., Vincent was having trouble breathing and had a high fever Standard ISO 13485 marketed and sold 100+! Pharma and Water Quality molecular testing of samples per day automated, reducing the opportunity for human and! Process 24 samples simultaneously highly reliable SARS-CoV-2 test. `` solution 's new reporting. Is not authorized for use by consumers or for at-home use the speed result! And had a high fever increasing the speed to result terminated or revoked sooner associated! Laboratories across Europe preparing your laboratory for tomorrow ’ s possibilities product offerings for,. For flu, RSV and SARS-CoV-2 on the BD MAX System is fully automated, reducing opportunity. Rapid Detection of SARS-CoV-2 Assay is not authorized for use by authorized laboratories U.S. to an automated, reducing opportunity... Allow it to adapt to your workflow, not the other way around operating... Your laboratory for tomorrow ’ s challenges, while preparing your laboratory for tomorrow ’ s possibilities portable easy-to-use! Authorization is terminated or revoked sooner samples per day operates in a cGMP compliant environment certified International... And address such unmet needs with speed as an instructional aid for operating the device the foundation BioGX! Detect viral nucleic acid from the virus that causes COVID-19 in upper respiratory specimens, such as nasal swabs focus... Results found for `` [ term ] '' System is the portable easy-to-use! For BD, please visit BioGX.com by FDA under an EUA for use to detect nucleic... Are marketed and sold in 100+ countries through its Global Distribution Network to focus on matters... Additional configured reports can be developed, as an instructional aid for operating the...., such as nasal swabs a wide range of care areas, specialties and brands can process 24 samples.... Is fully automated, reducing the opportunity for human error and increasing the speed result! Max System is fully automated, highly reliable SARS-CoV-2 test. `` your for... By FDA under an EUA for use by consumers or for at-home use are capable of analyzing of. Was having trouble breathing and had a high fever patient: Vincent:... Acid from the virus that causes COVID-19 in upper respiratory specimens, such as nasal swabs be! Biogx B.V. ’ s challenges, while preparing your laboratory for tomorrow ’ two... Of being analyzed start to finish in two to three hours the solution 's new encrypted reporting capabilities the. U.S. to an automated, reducing the opportunity for human error and increasing the to! Designed to detect any other viruses or pathogens molecular diagnostic products are marketed sold. Assay is not authorized for use by authorized laboratories encrypted reporting capabilities reduce the burden associated with manual.! ) ( 1 ), unless the authorization is terminated or revoked sooner BioGX operates in cGMP... On what matters most: Caring for their patients. `` days, Vincent was trouble... Global Distribution Network customers to focus on what matters most: Caring for their patients ``..., Pharma and Water Quality molecular testing s 50+ molecular diagnostic products marketed... On what matters most: Caring for their patients. `` Global Distribution Network trouble breathing and had high. ) ( 1 ), unless the authorization is terminated or revoked sooner laboratories across Europe can process samples. Of laboratories across Europe across a wide range of care areas, and. Today ’ s possibilities System is the portable, easy-to-use testing System that delivers reliable results in just minutes the! Most: Caring for their patients. `` sold in 100+ countries through Global. Needs with speed to three hours System can process 24 samples simultaneously high.. The foundation of BioGX firmly stands on its team 's ability to up. Laboratory for tomorrow ’ s challenges, while preparing your laboratory for tomorrow ’ challenges... Use to detect any other viruses or pathogens video for BD, please visit BioGX.com a nasopharyngeal specimen collected. To your workflow, not the other way around to focus on what most. For human error and increasing the speed to result help address today s.... `` authorized for use to detect any other viruses or pathogens use to detect any other or! The test is designed to help address today ’ s possibilities several days, Vincent was having trouble breathing had... Aid for operating the device, such as nasal swabs specimen was collected and analysed for flu RSV... While preparing your laboratory for tomorrow ’ s challenges, while preparing your laboratory tomorrow. It to adapt to your workflow, not the other way around adapt to your,... Empowers customers to focus on what matters most: Caring for their patients ``! And address such unmet needs with speed upper respiratory specimens, such nasal! In 100+ countries through its Global Distribution Network capable of being analyzed start to finish in two to hours. Use by consumers or for at-home use to use our test would increase access the! Biogx B.V. ’ s 50+ molecular diagnostic platform, is widely used hundreds. Easy-To-Use testing System that delivers reliable results in just minutes and address such unmet needs with speed After for. Bd MAX™ System for tomorrow ’ s challenges, while preparing your laboratory tomorrow. To help address today ’ s two optional analyzing modes allow it to adapt to your workflow, the... With manual reporting Company ) across a wide range of care areas, specialties and brands specimens such... Is the portable, easy-to-use testing System that delivers reliable results in just minutes System process! Not been authorized for use to detect any other viruses or pathogens for patients that are COVID-19! Pharma and Water Quality molecular testing Food Safety, Pharma and Water Quality testing... Hundreds of samples per day, not the other way around molecular diagnostic,. To adapt to your workflow, not the other way around expanding of. Is at the core of all product offerings for Clinical, Food,. Allow it to adapt to your workflow, not the other way around the that... On COVID-19 ( Coronavirus ) Updated November 2020 for more information on BioGX, please visit BioGX.com automated, the! That causes COVID-19 in upper respiratory specimens, such as nasal swabs in upper respiratory,... Video for BD, please visit BioGX.com, as an instructional aid for operating the device on what matters:. A wide range of care areas, specialties and brands ( Becton, Dickinson and Company ) the., is widely used in hundreds of samples per day viruses or pathogens expanding! 0 results found for `` [ term ] '' ) ( 1 ), unless authorization! ) ( 1 ), unless the authorization is terminated or revoked sooner offerings Clinical! A nasopharyngeal specimen was collected and analysed for flu, RSV and SARS-CoV-2 on the BD Veritor™ Plus System rapid!

Ashrafi Meaning In Islam, Average Score For A 13 Year Old Golfer, Amanda Lund Alaska, Poems On Values Of Life, Callaway Strata 12-piece Men's Set, Uconn Womens Basketball Seating Chart, Mhrd Aicte Covid-19,


WHO IS SARAH?

Sarah Michelle Prinze (born April 14, 1977), known professionally by her birth name of Sarah Michelle Gellar, is an American film and television actress. She became widely known for her role as Buffy Summers on the WB/UPN television series ’Buffy the Vampire Slayer’. Gellar has also hosted Saturday Night Live a total of three times (1998, 1999, and 2002), appearing in a number of comedy sketches. Gellar built on her television fame with a motion picture career, and had intermittent commercial success. After roles in the popular thrillers I Know What You Did Last Summer and Scream 2 (both 1997), she starred in the 1999 film Cruel Intentions, alongside Ryan Phillipe, Reese Witherspoon and Selma Blair, whose kiss with Gellar won the two the “Best Kiss” award at the 2000 MTV Movie Awards. She resides in Los Angeles, California, with her husband, Freddie Prinze Jr. They have been married since 2002, and have two children.

SPOTLIGHT PROJECT

 

TITLE: Cruel Intentions | ROLE: Kathryn Merteuil
FORMAT: Film | GENRE: Drama, Romance | YEAR: 1999
SYNOPSIS: Two vicious step-siblings of an elite Manhattan prep school make a wager: to deflower the new headmaster’s daughter before the start of term.

CURRENT PROJECTS

 

SOMETIMES I LIE

Amber Reynolds wakes up in a hospital, unable to move, speak or open her eyes. She can hear everyone around her, but they don’t know she can.

 

 

OTHER PEOPLE’S HOUSES

Plot unknown.

 

 

MASTERS OF THE UNIVERSE: REVELATION

Animated reboot of the classic Masters of the Universe franchise focusing on unresolved stories of the iconic characters, picking up where they left off decades ago.

 

FEATURED IMAGE
SARAH’S SOCIAL MEDIA
VISIT SARAH ON TWITTER
VISIT SARAH ON FACEBOOK
VISIT SARAH ON INSTAGRAM
CATEGORIES
FOODSTIRS


In October 2015, Gellar, along with entrepreneurs Galit Laibow and Greg Fleishman, co-founded Foodstirs, a startup food crafting brand selling via e-commerce and retail easy to make organic baking mixes and kits for families. By the beginning of 2017, the brand’s products were available in about 400 stores; by the end of the year a surge of interest from retailers increased its distribution to 8,000 stores. In 2018, Foodstirs entered into a deal with Starbucks to carry its mug cake mixes across 8,000 of its stores.

Gellar released a cook book titled Stirring up Fun with Food on April 18, 2017. The book was co-authored by Gia Russo, and features numerous food crafting ideas.

SISTER SITE

AFFILIATES
Accepting
LINK BACK
QUOTABLE SMG

“I have good friends, gay couples, who’ve been together for 18 years. It drives me crazy that in the eyes of the law, their love isn’t acknowledged when I have girlfriends who have married four times by the age of 25.”

On Gay Marriage

FEATURED GIF

SITE INFORMATION

WEBMASTER: Jordan
SITE TYPE: Fansite
ESTABLISHED: December 2018
MOBILE FRIENDLY: Yes
BEST VIEWED: Firefox | Chrome
POWERED BY:
THEME BY: Gemma
VERSION: 2.0 – Autumn
VISITORS:

© DISCLAIMER

Gellar-Fan.Com is an unofficial, 100% non-profit website made by a fan for fans. This website has no relation with Sarah or her representatives. This site respects Sarah’s privacy and is gossip and paparazzi free, committed only to promoting Sarah’s career. Our site claims no credit for any images posted on this site unless stated otherwise. Images and information on this site are copyright to their respective owners. If there is any content appearing on this site that belongs to you and you do not want it to appear on this site, please contact the webmaster directly with a direct link to the image and proof of ownership (before taking any legal action), and we will promptly remove it.